414 related articles for article (PubMed ID: 36792722)
1. Advances in NK cell therapy for brain tumors.
Fares J; Davis ZB; Rechberger JS; Toll SA; Schwartz JD; Daniels DJ; Miller JS; Khatua S
NPJ Precis Oncol; 2023 Feb; 7(1):17. PubMed ID: 36792722
[TBL] [Abstract][Full Text] [Related]
2. Exploring the NK cell platform for cancer immunotherapy.
Myers JA; Miller JS
Nat Rev Clin Oncol; 2021 Feb; 18(2):85-100. PubMed ID: 32934330
[TBL] [Abstract][Full Text] [Related]
3. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles.
Kim KS; Kim DH; Kim DH
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918941
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.
Dahlberg CI; Sarhan D; Chrobok M; Duru AD; Alici E
Front Immunol; 2015; 6():605. PubMed ID: 26648934
[TBL] [Abstract][Full Text] [Related]
6. Next Generation Natural Killer Cells for Cancer Immunotherapy.
Rossi F; Fredericks N; Snowden A; Allegrezza MJ; Moreno-Nieves UY
Front Immunol; 2022; 13():886429. PubMed ID: 35720306
[TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges.
Luzzi S; Giotta Lucifero A; Brambilla I; Magistrali M; Mosconi M; Savasta S; Foiadelli T
Acta Biomed; 2020 Jun; 91(7-S):18-31. PubMed ID: 32608373
[TBL] [Abstract][Full Text] [Related]
8. Next Generation Immuno-Oncology Strategies: Unleashing NK Cells Activity.
Mendoza-Valderrey A; Alvarez M; De Maria A; Margolin K; Melero I; Ascierto ML
Cells; 2022 Oct; 11(19):. PubMed ID: 36231109
[TBL] [Abstract][Full Text] [Related]
9. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas.
Bareke H; Ibáñez-Navarro A; Guerra-García P; González Pérez C; Rubio-Aparicio P; Plaza López de Sabando D; Sastre-Urgelles A; Ortiz-Cruz EJ; Pérez-Martínez A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176035
[TBL] [Abstract][Full Text] [Related]
10. Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies.
Seliger B; Koehl U
Front Immunol; 2022; 13():910595. PubMed ID: 36045670
[TBL] [Abstract][Full Text] [Related]
11. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer.
Elanany MM; Mostafa D; Hamdy NM
Life Sci; 2023 Oct; 330():121997. PubMed ID: 37536617
[TBL] [Abstract][Full Text] [Related]
12. Principles and current clinical landscape of NK cell engaging bispecific antibody against cancer.
Huan T; Guan B; Li H; Tu X; Zhang C; Tang B
Hum Vaccin Immunother; 2023 Aug; 19(2):2256904. PubMed ID: 37772505
[TBL] [Abstract][Full Text] [Related]
13. NK cells in the brain: implications for brain tumor development and therapy.
Balatsoukas A; Rossignoli F; Shah K
Trends Mol Med; 2022 Mar; 28(3):194-209. PubMed ID: 35078713
[TBL] [Abstract][Full Text] [Related]
14. Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors.
Quamine AE; Olsen MR; Cho MM; Capitini CM
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199783
[TBL] [Abstract][Full Text] [Related]
15. Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors.
Nayyar G; Chu Y; Cairo MS
Front Oncol; 2019; 9():51. PubMed ID: 30805309
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment.
Siu EH; Chan AW; Chong CC; Chan SL; Lo KW; Cheung ST
Transl Gastroenterol Hepatol; 2018; 3():89. PubMed ID: 30603725
[TBL] [Abstract][Full Text] [Related]
17. Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV.
Liu D; Tian S; Zhang K; Xiong W; Lubaki NM; Chen Z; Han W
Protein Cell; 2017 Dec; 8(12):861-877. PubMed ID: 28488245
[TBL] [Abstract][Full Text] [Related]
18. Weaponizing natural killer cells for solid cancer immunotherapy.
Wong JKM; Dolcetti R; Rhee H; Simpson F; Souza-Fonseca-Guimaraes F
Trends Cancer; 2023 Feb; 9(2):111-121. PubMed ID: 36379852
[TBL] [Abstract][Full Text] [Related]
19. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.
Shaver KA; Croom-Perez TJ; Copik AJ
Front Immunol; 2021; 12():679117. PubMed ID: 33995422
[TBL] [Abstract][Full Text] [Related]
20. The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.
Bald T; Krummel MF; Smyth MJ; Barry KC
Nat Immunol; 2020 Aug; 21(8):835-847. PubMed ID: 32690952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
